Oncofertility in Canada: The impact of cancer on fertility

Current Oncology

Volumn 20, Issue 4, 2013, Pages

  Ronn, R ^a   Holzer, H E G ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Adolescent; Cryopreservation; Fertility preservation; Gonadotoxicity; Oncofertility; Young adult

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; PLATINUM COMPLEX; PREDNISOLONE; PREDNISONE; PROCARBAZINE; TAXANE DERIVATIVE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

AMENORRHEA; ARTICLE; AZOOSPERMIA; BLADDER CANCER; BONE MARROW TRANSPLANTATION; BRAIN RADIATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; EJACULATION DISORDER; EXTERNAL BEAM RADIOTHERAPY; FEMALE INFERTILITY; HODGKIN DISEASE; HUMAN; INFERTILITY; LEUKEMIA; LYMPH NODE DISSECTION; LYMPHOMA; MULTIPLE CYCLE TREATMENT; OLIGOSPERMIA; OVARIAN RESERVE; OVARY INSUFFICIENCY; PARTIAL BODY RADIATION; PELVIC RADIOTHERAPY; PREGNANCY OUTCOME; PROSTATE CANCER; RECTUM CANCER; REPRODUCTIVE PROCEDURE; REPRODUCTIVE TOXICITY; SKULL IRRADIATION; TESTIS CANCER;

EID: 84881239450     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.20.1358     Document Type: Article

References (82)

1. Rosen A, Rodriguez-Wallberg KA, Rosenzweig L. Psychosocial distress in young cancer survivors. Semin Oncol Nurs 2009;25:268-77.
2. Woodruff TK. The emergence of a new interdiscipline: oncofertility. Cancer Treat Res 2007;138:3-11.
3. Yee S, Buckett W, Campbell S, Yanofsky RA, Barr RD., A national study of the provision of oncology sperm banking services among Canadian fertility clinics. Eur J Cancer Care (Engl) 2013;:[Epub ahead of print].
4. Yee S, Buckett W, Campbell S, Yanofsky R, Barr RD. A national study of the provision of oncofertility services to female patients in Canada. J Obstet Gynaecol Can 2012;3:849-58.
5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. globocan 2008 [Web resource]. Lyon, France: International Agency for Research on Cancer; 2010. [Available at: http://globocan.iarc.fr; cited February 11, 2012]
6. Ellison LF, Wilkins K. Canadian trends in cancer prevalence. Health Rep 2012;23:7-16.
7. Statistics Canada. Cancer, New Cases, by Selected Primary Site of Cancer, by Sex [Web page]. Ottawa, ON: Statistics Canada; 2011. [Available at: http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/hlth61-eng.htm; cited February 9, 2012]
8. Yee S, Fuller-Thomson E, Lau A, Greenblatt EM. Fertility preservation practices among Ontario oncologists. J Cancer Educ 2012;27:362-8.
9. American Cancer Society. Cancer Facts and Figures 2005. Atlanta, GA: American Cancer Society; 2005: 1-64.
10. Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med 2009;360:902-11.
11. Statistics Canada. Cancer Survival Statistics 1992 to 2003. Ottawa, ON: Statistics Canada; 2012. [Available online at: http://www.statcan.gc.ca/pub/82-226-x/82-226-x2012001-eng.pdf; cited February 9, 2012]
12. Ellison LF, Wilkins K. An update on cancer survival. Health Rep 2010;21:55-60.
13. Hickey M, Peate M, Saunders CM, Friedlander M. Breast cancer in young women and its impact on reproductive function. Hum Reprod Update 2009;15:323-39.
14. Levine J, Canada A, Stern CJ. Fertility preservation in adolescents and young adults with cancer. J Clin Oncol 2010;28:4831-41.
15. Yao MWM, Batchu K. Oogenesis. In: Falcone T, Hurd WW, eds. Clinical Reproductive Medicine and Surgery. Philadelphia, PA: Mosby/Elsevier; 2007: 51-72.
16. The ovary, embryology and development. In: Fritz MA, Speroff L. Clinical Gynecologic Endocrinology and Infertility. 8th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2011: 105-120.
17. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009;30:465-43.
18. Committee on Gynecologic Practice of American College of Obstetricians and Gynecologists, Practice Committee of American Society for Reproductive Medicine. Age-related fertility decline: a committee opinion. Fertil Steril 2008;90(suppl):S154-5.
19. White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med 2012;18:413-21.
20. Knopman JM, Papadopoulos EB, Grifo JA, Fino ME, Noyes N. Surviving childhood and reproductive-age malignancy: effects on fertility and future parenthood. Lancet Oncol 2010;11:490-8.
21. Pavone ME, Hirshfeld-Cytron JE, Kazer RR. The progressive simplification of the infertility evaluation. Obstet Gynecol Surv 2011;66:31-41.
22. Duncan FE, Jozefik JK, Kim AM, Hirshfeld-Cytron J, Woodruff TK. The gynecologist has a unique role in providing oncofertility care to young cancer patients. US Obstet Gynecol 2011;6:24-34.
23. Magelssen H, Brydøy M, Fosså SD. The effects of cancer and cancer treatments on male reproductive function. Nat Clin Pract Urol 2006;3:312-22.
24. Hobbie WL, Ogle SK, Ginsberg JP. Fertility concerns for young males undergoing cancer therapy. Semin Oncol Nurs 2009;25:245-50.
25. Meirow D, Dor J, Kaufman B, et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod 2007;22:1626-33.
26. Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 2010;53:727-39.
27. Fleischer RT, Vollenhoven BJ, Weston GC. The effects of chemotherapy and radiotherapy on fertility in premenopausal women. Obstet Gynecol Surv 2011;66:248-54.
28. von Wolff M, Montag M, Dittrich R, Denschlag D, Nawroth F, Lawrenz B. Fertility preservation in women-a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network fertiprotekt. Arch Gynecol Obstet 2011;284:427-35.
29. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;14:1718-29.
30. Chen H, Li J, Cui T, Hu L. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev 2011;:CD008018.
31. Schimmer AD, Quatermain M, Imrie K, et al. Ovarian function after autologous bone marrow transplantation. J Clin Oncol 1998;16:2359-63.
32. Gadducci A, Cosio S, Genazzani AR. Ovarian function and childbearing issues in breast cancer survivors. Gynecol Endocrinol 2007;23:625-31.
33. Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999;17:2365-70.
34. Letourneau JM, Ebbel EE, Katz PP, et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer 2012;118:1933-9.
35. Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk Lymphoma 1999;33:65-76.
36. Behringer K, Breuer K, Reineke T, et al. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 2005;23:7555-64.
37. Langan RC, Prieto PA, Sherry RM, et al. Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy. J Immunother 2011;34:397-402.
38. Tempone A. Ovarian function preservation in patients under chemotherapy treatment. Gynecol Endocrinol 2008;24:481-2.
39. Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 2006;24:5769-79.
40. Minton SE, Munster PN. Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer. Cancer Control 2002;9:466-72.
41. Reh A, Oktem O, Oktay K. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers. Fertil Steril 2008;90:1635-9.
42. Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer 2010;116:791-8.
43. Noyes N, Knopman JM, Long K, Coletta JM, Abu-Rustum NR. Fertility considerations in the management of gynecologic malignancies. Gynecol Oncol 2011;120:326-33.
44. Lutchman Singh K, Muttukrishna S, Stein RC, et al. Predictors of ovarian reserve in young women with breast cancer. Br J Cancer 2007;96:1808-16.
45. Anderson RA, Cameron DA. Assessment of the effect of chemotherapy on ovarian function in women with breast cancer. J Clin Oncol 2007;25:1630-1.
46. Broekmans FJ, Knauff EA, te Velde ER, Macklon NS, Fauser BC. Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab 2007;18:58-65.
47. Anderson RA, Themmen AP, Al-Qahtani A, Groome NP, Cameron DA. The effects of chemotherapy and longterm gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 2006;21:2583-92.
48. Lambalk CB, van Disseldorp J, de Koning CH, Broekmans FJ., Testing ovarian reserve to predict age at menopause. Maturitas 2009;63:280-91.
49. Liu K, Case A, Reproductive Endocrinology and Infertility Committee, Family Physicians Advisory Committee, Maternal- Fetal Medicine Committee, Executive and Council of the Society of Obstetricians. Advanced reproductive age and fertility. J Obstet Gynaecol Can 2011;33:1165-75.
50. Signorello LB, Mulvihill JJ, Green DM, et al. Congenital anomalies in the children of cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2012;30:239-45.
51. Winther JF, Boice JD Jr, Mulvihill JJ, et al. Chromosomal abnormalities among offspring of childhood-cancer survivors in Denmark: a population-based study. Am J Hum Genet 2004;74:1282-5.
52. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod 2003;18:117-21.
53. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005;62:738-44.
54. Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr 2005;(34):64-8.
55. Adriaens I, Smitz J, Jacquet P. The current knowledge on radiosensitivity of ovarian follicle development stages. Hum Reprod Update 2009;15:359-77.
56. Critchley HO, Bath LE, Wallace WH. Radiation damage to the uterus-review of the effects of treatment of childhood cancer. Hum Fertil (Camb) 2002;5:61-6.
57. Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 2009;73:1304-12.
58. Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer 1989;43:399-402.
59. O'Neill MT, Ni Dhonnchu T, Brannigan AE. Topic update: effects of colorectal cancer treatments on female fertility and potential methods for fertility preservation. Dis Colon Rectum 2011;54:363-9.
60. Bath LE, Anderson RA, Critchley HO, Kelnar CJ, Wallace WH. Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Hum Reprod 2001;16:1838-44.
61. Constine LS, Woolf PD, Cann D, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993;328:87-94.
62. Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003;18:2368-74.
63. Marhhom E, Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv 2006;62:58-72.
64. Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ, Bristow RE. Fertility preserving options in patients with gynecologic malignancies. Am J Obstet Gynecol 2011;205:103-10.
65. Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol 2007;25:2938-43.
66. Donnez J, Squifflet J, Donnez O. Minimally invasive gynecologic procedures. Curr Opin Obstet Gynecol 2011;23:289-95.
67. Jahnukainen K, Ehmcke J, Hou M, Schlatt S. Testicular function and fertility preservation in male cancer patients. Best Pract Res Clin Endocrinol Metab 2011;25:287-302.
68. Stahl PJ, Stember DS, Hsiao W, Schlegel PN. Indications and strategies for fertility preservation in men. Clin Obstet Gynecol 2010;53:815-27.
69. Giwercman A, Petersen PM. Cancer and male infertility. Baillieres Best Pract Res Clin Endocrinol Metab 2000;14:453-71.
70. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005;(34):12-17.
71. Ash P. The influence of radiation on fertility in man. Br J Radiol 1980;53:271-8.
72. Mazonakis M, Damilakis J, Varveris H, Gourtsouiannis N. Radiation dose to testes and risk of infertility from radiotherapy for rectal cancer. Oncol Rep 2006;15:729-33.
73. Couto-Silva AC, Trivin C, Esperou H, et al. Final height and gonad function after total body irradiation during childhood. Bone Marrow Transplant 2006;38:427-32.
74. Rovó A, Tichelli A, Passweg JR, et al. Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic gvhd. Blood 2006;108:1100-5.
75. Dohle GR. Male infertility in cancer patients: review of the literature. Int J Urol 2010;17:327-31.
76. Abouassaly R, Fossa SD, Giwercman A, et al. Sequelae of treatment in long-term survivors of testis cancer. Eur Urol 2011;60:516-26.
77. Petersen PM, Skakkebaek NE, Rørth M, Giwercman A. Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer. J Urol 1999;161:822-6.
78. Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Male Reproduction and Urology. Evaluation of the azoospermic male. Fertil Steril 2008;90(suppl):S74-7.
79. Rueffer U, Breuer K, Josting A, et al. Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann Oncol 2001;12:1307-11.
80. van der Kaaij MA, Heutte N, van Echten-Arends J, et al. Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in eortc-gela Lymphoma Group trials. Haematologica 2009;94:1691-7.
81. Sieniawski M, Reineke T, Josting A, et al. Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (ghsg) clinical trials. Ann Oncol 2008;19:1795-801.
82. Sabanegh ES Jr, Ragheb AM. Male fertility after cancer. Urology 2009;73:225-31.